Skip to main content
main-content

Zeitschrift

Annals of Surgical Oncology

Annals of Surgical Oncology 2/2021

Ausgabe 2/2021

Inhaltsverzeichnis ( 85 Artikel )

24.11.2020 | Health Services Research and Global Oncology | Ausgabe 2/2021

2020 SSO Presidential Address: Surgical Oncology Moonshot

David L. Bartlett

29.09.2020 | Thoracic Oncology | Ausgabe 2/2021

Comments on: Lower Incidence of Postoperative Pulmonary Complications Following Robot-Assisted Minimally Invasive Esophagectomy for Esophageal Cancer: Propensity Score-Matched Comparison to Conventional Minimally Invasive Esophagectomy

Rupen Shah, Zane Hammoud

22.10.2020 | Thoracic Oncology | Ausgabe 2/2021

Is Newer Actually Better? Where Does the 8th Edition Outperform the 7th Edition of the Esophageal TNM Staging System?

Siva Raja MD, PhD, Usman Ahmad MD

27.10.2020 | Thoracic Oncology | Ausgabe 2/2021

Don’t Anger the Host: New Etiquette in Standard Cancer Assessment?

Kei Suzuki MD, Virginia R. Litle MD

22.11.2020 | Hepatobiliary Tumors | Ausgabe 2/2021

Tumor Necrosis in Hepatocellular Carcinoma—Unfairly Overlooked?

Lana Bijelic MD, Emilio Ramos Rubio MD

09.11.2020 | Head and Neck Oncology | Ausgabe 2/2021

Time to Surgery and Survival in Head and Neck Cancer

Molly E. Heft Neal MD, Katie K. Spielbauer MD, Matthew E. Spector MD

11.11.2020 | Head and Neck Oncology | Ausgabe 2/2021

Editorial Comment on “Enhanced Recovery After Surgery (ERAS) in Head and Neck Oncologic Surgery: A Case-Matched Analysis of Perioperative and Pain Outcomes”

Shuqing Chen MS, Baran D. Sumer MD, FACS

07.07.2020 | Health Services Research and Global Oncology | Ausgabe 2/2021

Refusal of Cancer-Directed Surgery in Patients with Colon Cancer: Risk Factors of Refusal and Survival Data

Gabriel S. Makar MD, Michael Makar MD, Chioma Obinero MD, William Davis MD, John P. Gaughan MS, PhD, MBA, Michael Kwiatt MD

22.07.2020 | Health Services Research and Global Oncology | Ausgabe 2/2021

Association of Neighborhood Characteristics with Utilization of High-Volume Hospitals Among Patients Undergoing High-Risk Cancer Surgery

Adrian Diaz MD, Daniel Chavarin BS, Anghela Z. Paredes MD, MS, Diamantis I. Tsilimigras MD, Timothy M. Pawlik MD, MPH, MTS, PhD

25.07.2020 | Health Services Research and Global Oncology | Ausgabe 2/2021

Improving the Quality of Cancer Care in Community Hospitals

Thomas C. Tucker PhD, MPH, Mary E. Charlton PhD, Mary C. Schroeder PhD, Jason Jacob MS, Cheri L. Tolle MAEd, CHES, B. Mark Evers MD, FACS, Timothy W. Mullett MD, MBA, FACS

05.09.2020 | Thoracic Oncology | Ausgabe 2/2021

Lower Incidence of Postoperative Pulmonary Complications Following Robot-Assisted Minimally Invasive Esophagectomy for Esophageal Cancer: Propensity Score-Matched Comparison to Conventional Minimally Invasive Esophagectomy

Shigeru Tsunoda MD, PhD, FACS, Kazutaka Obama MD, PhD, FACS, Shigeo Hisamori MD, PhD, FACS, Tatsuto Nishigori MD, PhD, FACS, Ryosuke Okamura MD, PhD, Hisatsugu Maekawa MD, PhD, Yoshiharu Sakai MD, PhD, FACS

31.08.2020 | ASO Author Reflections | Ausgabe 2/2021

ASO Author Reflections: Clinical Benefit of Robot-Assisted Minimally Invasive Esophagectomy over Conventional Minimally Invasive Esophagectomy

Shigeru Tsunoda MD, PhD, FACS, Kazutaka Obama MD, PhD, FACS

06.10.2020 | Thoracic Oncology | Ausgabe 2/2021

Clinical Utility of ypTNM Stage Grouping in the 8th Edition of the American Joint Committee on Cancer TNM Staging System for Esophageal Squamous Cell Carcinoma

Natsuru Sudo MD, PhD, Hiroshi Ichikawa MD, PhD, Yusuke Muneoka MD, PhD, Takaaki Hanyu MD, PhD, Yosuke Kano MD, PhD, Takashi Ishikawa MD, PhD, Yuki Hirose MD, PhD, Kohei Miura MD, PhD, Yoshifumi Shimada MD, PhD, Masayuki Nagahashi MD, PhD, Jun Sakata MD, PhD, Takashi Kobayashi MD, PhD, Takeo Bamba MD, PhD, Satoru Nakagawa MD, PhD, Shin-ichi Kosugi MD, PhD, Toshifumi Wakai MD, PhD, FACS

01.10.2020 | ASO Author Reflections | Ausgabe 2/2021

ASO Author Reflections: ypTNM Stage Grouping in the 8th Edition of the AJCC Cancer Staging Manual Refines the Prognostic Prediction for Patients with Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Chemotherapy

Natsuru Sudo MD, PhD, Hiroshi Ichikawa MD, PhD, Yusuke Muneoka MD, PhD, Takaaki Hanyu MD, PhD, Yosuke Kano MD, PhD, Takashi Ishikawa MD, PhD, Yuki Hirose MD, PhD, Kohei Miura MD, PhD, Yoshifumi Shimada MD, PhD, Masayuki Nagahashi MD, PhD, Jun Sakata MD, PhD, Takashi Kobayashi MD, PhD, Takeo Bamba MD, PhD, Satoru Nakagawa MD, PhD, Shin-ichi Kosugi MD, PhD, Toshifumi Wakai MD, PhD, FACS

09.07.2020 | Thoracic Oncology | Ausgabe 2/2021

Refusal of Local Therapy in Esophageal Cancer and Impact on Overall Survival

Matthew Parsons MD, Shane Lloyd MD, Skyler Johnson MD, Courtney Scaife MD, Thomas Varghese MD, MS, Robert Glasgow MD, Ignacio Garrido-Laguna MD, PhD, Randa Tao MD

27.07.2020 | Thoracic Oncology | Ausgabe 2/2021

Assessment of Quality Outcomes and Learning Curve for Robot-Assisted Minimally Invasive McKeown Esophagectomy

Yang Yang MD, Bin Li MD, Rong Hua MD, Xiaobin Zhang MD, Haoyao Jiang MD, Yifeng Sun MD, Giulia Veronesi MD, Sara Ricciardi MD, Monica Casiraghi MD, IEO, Marion Durand MD, PhD, Raul Caso MD, Inderpal S. Sarkaria MD, FACS, ZhiGang Li MD, Written on behalf of the AME Thoracic Surgery Collaborative Group

16.07.2020 | Thoracic Oncology | Ausgabe 2/2021

Prognostic Impact of Smoking Period in Patients with Surgically Resected Non-small Cell Lung Cancer

Shinkichi Takamori MD, PhD, Mototsugu Shimokawa MD, PhD, Taichi Matsubara MD, PhD, Naoki Haratake MD, PhD, Ryo Toyozawa MD, Naoko Miura MD, PhD, Masafumi Yamaguchi MD, PhD, Takashi Seto MD, PhD, Tetsuzo Tagawa MD, PhD, Tatsuro Okamoto MD, PhD, Mitsuhiro Takenoyama MD, PhD, Yoshihiko Maehara MD, PhD, Masaki Mori MD, PhD

07.07.2020 | Thoracic Oncology | Ausgabe 2/2021

Digestive Reconstruction After Pharyngolaryngectomy with Total Esophagectomy

Akihiko Okamura MD, Masayuki Watanabe MD, Jun Kanamori MD, Yu Imamura MD, Keita Takahashi MD, Yuta Ushida MD, Ryosuke Kamiyama MD, Akira Seto MD, Wataru Shimbashi MD, Toru Sasaki MD, Hirofumi Fukushima MD, Hiroyuki Yonekawa MD, Hiroki Mitani MD

09.07.2020 | Thoracic Oncology | Ausgabe 2/2021

Completely Minimally Invasive Esophagectomy Versus Hybrid Esophagectomy for Esophageal and Gastroesophageal Junctional Cancer: Clinical and Short-Term Oncological Outcomes

Krashna Patel FRCS, Omar Abbassi MRCS, Cheuk Bong Tang FRCS, MD, Bruno Lorenzi PhD, Alexandros Charalabopoulos FRCS, PhD, Sritharan Kadirkamanathan FRCS, PhD, Naga Venkatesh Jayanthi FRCS, MD

05.08.2020 | Thoracic Oncology | Ausgabe 2/2021

Long-Term Outcome of Patients with Locally Advanced Clinically Unresectable Esophageal Cancer Undergoing Conversion Surgery after Induction Chemotherapy with Docetaxel Plus Cisplatin and 5-Fluorouracil

Tetsuya Abe MD, PhD, Eiji Higaki MD, PhD, Takahiro Hosoi MD, Takuya Nagao MD, Hideaki Bando MD, PhD, Shigenori Kadowaki MD, PhD, Kei Muro MD, PhD, Tsutomu Tanaka MD, PhD, Masahiro Tajika MD, PhD, Yasumasa Niwa MD, PhD, Yasuhiro Shimizu MD, PhD

05.09.2020 | Pancreatic Tumors | Ausgabe 2/2021 Open Access

Staging the Tumor and Staging the Host: Pretreatment Combined Neutrophil Lymphocyte Ratio and Modified Glasgow Prognostic Score Is Associated with Overall Survival in Patients with Esophagogastric Cancers Undergoing Treatment with Curative Intent

Stephen T. McSorley PhD, MRCS, Hiu Y. N. Lau BSc, David McIntosh FRCP, Matthew J. Forshaw FRCS, Donald C. McMillan PhD, Andrew B. Crumley MD, FRCS

11.07.2020 | Gastrointestinal Oncology | Ausgabe 2/2021

It Is Time to Rethink Biomarkers for Surveillance of Small Bowel Neuroendocrine Tumors

Catherine G. Tran MD, Scott K. Sherman MD, Aaron T. Scott MD, Po Hien Ear PhD, Chandrikha Chandrasekharan MBBS, Andrew M. Bellizzi MD, Joseph S. Dillon MB, BCh, Thomas M. O’Dorisio MD, James R. Howe MD

11.07.2020 | Gastrointestinal Oncology | Ausgabe 2/2021

Robotic Gastrectomy for Gastric Adenocarcinoma in the USA: Insights and Oncologic Outcomes in 220 Patients

Vivian E. Strong MD, Ashley E. Russo MD, Masaya Nakauchi MD, Mark Schattner MD, Luke V. Selby MD, Gabriel Herrera MD, Laura Tang MD, Mithat Gonen PhD

20.07.2020 | Gastrointestinal Oncology | Ausgabe 2/2021

Management of Appendiceal Neuroendocrine Tumors: Metastatic Potential of Small Tumors

Jace P. Landry MD, Brianne A. Voros MS, Robert A. Ramirez DO, FACP, J. Philip Boudreaux MD, FACS, Eugene A. Woltering MD, FACS, Ramcharan Thiagarajan MBBS, FACS

21.07.2020 | Gastrointestinal Oncology | Ausgabe 2/2021

Chemotherapy Versus Chemotherapy Plus Chemoradiation as Preoperative Therapy for Resectable Gastric Adenocarcinoma: A Propensity Score-Matched Analysis of a Large, Single-Institution Experience

Casey J. Allen MD, Alisa N. Blumenthaler MD, Grace L. Smith MD, Prajnan Das MD, Bruce D. Minsky MD, Mariela Blum MD, Jaffer Ajani MD, Paul F. Mansfield MD, Naruhiko Ikoma MD, Brian D. Badgwell MD

31.07.2020 | Gastrointestinal Oncology | Ausgabe 2/2021

Prognostic Significance of Complete Pathologic Response Obtained with Chemotherapy Versus Chemoradiotherapy in Gastric Cancer

Denslow A. Trumbull BS, Riccardo Lemini MD, Tamara Díaz Vico MD, Matthew S. Jorgensen BS, Kristopher Attwood PhD, Wenyan Ji MA, Maureen Brady PA, Emmanuel Gabriel MD, PhD, Moshim Kukar MD

31.07.2020 | Gastrointestinal Oncology | Ausgabe 2/2021

Validation Study of Fibrinogen and Albumin Score in Esophageal Cancer Patients Who Underwent Esophagectomy: Multicenter Prospective Cohort Study

Satoru Matsuda MD, PhD, Hiroya Takeuchi MD, PhD, Hirofumi Kawakubo MD, PhD, Ryo Takemura MD, PhD, Yusuke Maeda MD, Yuki Hirata MD, Takuji Kaburagi MD, PhD, Tomohisa Egawa MD, PhD, Tomohiko Nishi MD, PhD, Masaharu Ogura MD, PhD, Taku Miyasho PhD, Akihiko Okamura MD, PhD, Shuhei Mayanagi MD, PhD, Kazumasa Fukuda PhD, Rieko Nakamura MD, PhD, Tomoyuki Irino MD, PhD, Norihito Wada MD, PhD, Yuko Kitagawa MD, PhD

01.08.2020 | Gastrointestinal Oncology | Ausgabe 2/2021

Disparate and Alarming Impact of Gastrointestinal Cancers in Young Adult Patients

Amir Khan MD, Philip H. G. Ituarte PhD, Mustafa Raoof MD, Laleh Melstrom MD, Haiqing Li PhD, Yate-Ching Yuan PhD, Lily Lai MD, I. Benjamin Paz MD, Ajay Goel PhD, Yuman Fong MD, Yanghee Woo MD, FACS

28.11.2020 | Hepatobiliary Tumors | Ausgabe 2/2021

Tumor Necrosis Impacts Prognosis of Patients Undergoing Curative-Intent Hepatocellular Carcinoma

Tao Wei MD, PhD, Xu-Feng Zhang MD, Fabio Bagante MD, Francesca Ratti MD, Hugo P. Marques MD, Silvia Silva MD, Olivier Soubrane MD, Vincent Lam MD, George A. Poultsides MD, Irinel Popescu MD, Razvan Grigorie MD, PhD, Sorin Alexandrescu MD, Guillaume Martel MD, Aklile Workneh MD, Alfredo Guglielmi MD, Tom Hugh MD, Luca Aldrighetti MD, Itaru Endo MD, PhD, Timothy M. Pawlik MD, MPH, PhD, FACS, FRACS (Hon.)

25.11.2020 | ASO Author Reflections | Ausgabe 2/2021

ASO Author Reflections: Hepatocellular Carcinoma-Related Tumor Necrosis is Associated with Worse Long-Term Outcomes

Xu-Feng Zhang MD, Timothy M. Pawlik MD, MPH, MTS, PhD

09.07.2020 | Hepatobiliary Tumors | Ausgabe 2/2021 Open Access

Recurrence After Liver Resection of Colorectal Liver Metastases: Repeat Resection or Ablation Followed by Hepatic Arterial Infusion Pump Chemotherapy

Florian E. Buisman MD, Wills F. Filipe MD, Nancy E. Kemeny MD, Raja R. Narayan MD MPH, Rami M. Srouji MD, Vinod P. Balachandran MD, Thomas Boerner MD, Jeffrey A. Drebin MD PhD, William R. Jarnagin MD, T. Peter Kingham MD, Alice C. Wei MD, Dirk J. Grünhagen MD PhD, Cornelis Verhoef MD PhD, Bas Groot Koerkamp MD PhD, Michael I. D’Angelica MD FACS

18.07.2020 | Hepatobiliary Tumors | Ausgabe 2/2021

Association of RAS Mutation Location and Oncologic Outcomes After Resection of Colorectal Liver Metastases

Lily V. Saadat MD, Thomas Boerner MD, Debra A. Goldman MS, Mithat Gonen PhD, Timothy L. Frankel MD, Efsevia Vakiani MD, PhD, T. Peter Kingham MD, William R. Jarnagin MD, Alice C. Wei MD, Kevin C. Soares MD, David B. Solit MD, Michael I. D’Angelica MD

10.07.2020 | Hepatobiliary Tumors | Ausgabe 2/2021

Prognostic Factors for Surgically Resected Intraductal Papillary Neoplasm of the Bile Duct: A Retrospective Cohort Study

Shuichiro Uemura MD, PhD, Ryota Higuchi MD, PhD, Takehisa Yazawa MD, PhD, Wataru Izumo MD, PhD, Yutaro Matsunaga MD, Masahiro Shiihara MD, Takehiro Ota MD, PhD, Toru Furukawa MD, PhD, Masakazu Yamamoto MD, PhD

21.07.2020 | Hepatobiliary Tumors | Ausgabe 2/2021 Open Access

Extended Resections for Advanced Gallbladder Cancer: Results from a Nationwide Cohort Study

H. Kuipers BSc, E. A. J. de Savornin Lohman MD, M. van Dooren BSc, A. E. Braat MD, PhD, F. Daams MD, PhD, R. van Dam MD, PhD, J. I. Erdmann MD, PhD, J. Hagendoorn MD, PhD, F. J. H. Hoogwater MD, PhD, B. Groot Koerkamp MD, PhD, T. M. van Gulik MD, PhD, P. R. de Reuver MD, PhD, M. T. de Boer MD, PhD

25.07.2020 | Hepatobiliary Tumors | Ausgabe 2/2021

Successful Anatomic Resection of Tumor-Bearing Portal Territory Delays Long-Term Stage Progression of Hepatocellular Carcinoma

Junichi Shindoh MD, PhD, Yuta Kobayashi MD, Ryosuke Umino MD, Kazutaka Kojima MD, Satoshi Okubo MD, PhD, Masaji Hashimoto MD, PhD

01.08.2020 | Hepatobiliary Tumors | Ausgabe 2/2021

Is Portal Vein Embolization Followed by Hepatectomy for Hepatocellular Carcinoma Justified in Patients with Impaired Liver Function?

Katsunori Imai MD, PhD, FACS, Yo-ichi Yamashita MD, PhD, FACS, Yosuke Nakao MD, Takashi Matsumoto MD, Shotaro Kinoshita MD, Toshihiko Yusa MD, Yuki Kitano MD, PhD, Takayoshi Kaida MD, PhD, Hiromitsu Hayashi MD, PhD, FACS, Hideo Baba MD, PhD, FACS

19.08.2020 | Hepatobiliary Tumors | Ausgabe 2/2021

Simultaneous Sigmoid Colectomy, Bilobar Liver Resection and Lung Metastasectomy via a Transdiaphragmatic Approach for Stage IV Colonic Adenocarcinoma

Mario De Bellis MD, Eduardo A. Vega MD, Yoshikuni Kawaguchi MD, PhD, Elena Panettieri MD, Jenilette D. Velasco MD, Timothy J. Vreeland MD, Y Nancy You MD, Allen A. Holmes MD, Reza J. Mehran MD, Jean-Nicolas Vauthey MD

07.07.2020 | Hepatobiliary Tumors | Ausgabe 2/2021

First Case of Full Robotic ALPPS for Intrahepatic Cholangiocarcinoma

Fabrizio Di Benedetto MD, PhD, FACS, Paolo Magistri MD

13.07.2020 | Hepatobiliary Tumors | Ausgabe 2/2021

Clamp–Crush Technique for Laparoscopic Liver Resection

Takeo Nomi MD, PhD, Daisuke Hokuto MD, PhD, Takahiro Yoshikawa MD, PhD, Naoki Kamitani MD, Yasuko Matsuo MD, Masayuki Sho MD, PhD

22.09.2020 | Head and Neck Oncology | Ausgabe 2/2021

Enhanced Recovery After Surgery (ERAS) in Head and Neck Oncologic Surgery: A Case-Matched Analysis of Perioperative and Pain Outcomes

Kimberley L. Kiong MBBS, Catherine N. Vu MD, Christopher M. K. L. Yao MD, Brittany Kruse BA, Gang Zheng MD, Peirong Yu MD, Randal S. Weber MD, Carol M. Lewis MD, MPH

13.11.2020 | Head and Neck Oncology | Ausgabe 2/2021

Time to Surgery and Survival in Head and Neck Cancer

Chandler J. Rygalski BS, Songzhu Zhao MS, Antoine Eskander MD, ScM, Kevin Y. Zhan MD, Edmund A. Mroz PhD, Guy Brock PhD, Dustin A. Silverman MD, Dukagjin Blakaj MD, PhD, Marcelo R. Bonomi MD, Ricardo L. Carrau MD, MBA, Matthew O. Old MD, James W. Rocco MD, PhD, Nolan B. Seim MD, Sidharth V. Puram MD, PhD, Stephen Y. Kang MD

13.11.2020 | ASO Author Reflections | Ausgabe 2/2021

ASO Author Reflections: Head and Neck Cancer Surgery—How Long Can it Wait?

Chandler J. Rygalski BS, Songzhu Zhao MS, Antoine Eskander MD, ScM, Sidharth V. Puram MD, PhD, Stephen Y. Kang MD

20.08.2020 | Breast Oncology | Ausgabe 2/2021

Sentinel Lymph Node Removal After Neoadjuvant Chemotherapy in Clinically Node-Negative Patients: When to Stop?

Brittany L. Murphy MD, MS, James W. Jakub MD, Malke Asaad MD, Courtney N. Day BS, Tanya L. Hoskin MS, Elizabeth B. Habermann PhD, MPH, Judy C. Boughey MD

07.07.2020 | Breast Oncology | Ausgabe 2/2021

Lowering Re-excision Rates After Breast-Conserving Surgery: Unraveling the Intersection Between Surgeon Case Volumes and Techniques

Christopher Baliski MD, FRCSC, Lauren Hughes BSc, Brendan Bakos MSc

10.07.2020 | Breast Oncology | Ausgabe 2/2021

Trends in Breast Cancer Treatment De-Implementation in Older Patients with Hormone Receptor-Positive Breast Cancer: A Mixed Methods Study

Ton Wang MD, Alison Baskin BA, Jacquelyn Miller MA, Allan Metz BS, Niki Matusko BS, Tasha Hughes MD, MPH, Michael Sabel MD, Jacqueline S. Jeruss MD, PhD, Lesly A. Dossett MD, MPH

13.07.2020 | Breast Oncology | Ausgabe 2/2021

Breast-Conserving Therapy is Associated with Improved Survival Compared with Mastectomy for Early-Stage Breast Cancer: A Propensity Score Matched Comparison Using the National Cancer Database

Erica Wrubel MD, Raylene Natwick MD, G. Paul Wright MD

23.07.2020 | Breast Oncology | Ausgabe 2/2021

Axillary Management in Women with Early Breast Cancer and Limited Sentinel Node Metastasis: A Systematic Review and Metaanalysis of Real-World Evidence in the Post-ACOSOG Z0011 Era

Tzu-Wen Huang MS, Chih-Ming Su MD, PhD, Ka-Wai Tam MD, PhD

25.07.2020 | Breast Oncology | Ausgabe 2/2021

Omission of Axillary Lymph Node Dissection is Associated with Inferior Survival in Breast Cancer Patients with Residual N1 Nodal Disease Following Neoadjuvant Chemotherapy

Muayad F. Almahariq MD, PhD, Ronald Levitin MD, Thomas J. Quinn MD, Peter Y. Chen MD, Nayana Dekhne MD, Sayee Kiran MD, Amita Desai MD, Pamela Benitez MD, Maha S. Jawad MD, Gregory S. Gustafson MD, Joshua T. Dilworth MD, PhD

27.07.2020 | Breast Oncology | Ausgabe 2/2021

Medical Maximizing–Minimizing Preferences in Relation to Low-Value Services for Older Women with Hormone Receptor-Positive Breast Cancer: A Qualitative Study

Nicole Mott BS, Ton Wang MD, Jacquelyn Miller MA, Nicholas L. Berlin MD, MPH, Sarah Hawley PhD, MPH, Reshma Jagsi MD, DPhil, Brian J. Zikmund-Fisher PhD, Lesly A. Dossett MD, MPH

30.07.2020 | Breast Oncology | Ausgabe 2/2021

Gaps in Online Breast Cancer Treatment Information for Older Women

Alison S. Baskin BA, Ton Wang MD, MS, Nicole M. Mott BS, Sarah T. Hawley PhD, MPH, Reshma Jagsi MD, DPhil, Lesly A. Dossett MD, MPH

28.07.2020 | Breast Oncology | Ausgabe 2/2021

Combining Wire Localization of Clipped Nodes with Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Node-Positive Breast Cancer: Preliminary Results from a Prospective Study

Alejandra García-Novoa MD, PhD, Benigno Acea-Nebril MD, PhD, Carlota Díaz Carballada MD, Alberto Bouzón Alejandro MD, PhD, Carmen Conde MD, Carmen Cereijo Garea PhD, José Ramón Varela MD, Paz Santiago Freijanes MD, Silvia Antolín Novoa MD, Lourdes Calvo Martínez MD, PhD, Inma Díaz MD, Sofia Rodríguez Martínez MD, Joaquin Mosquera Oses MD

19.08.2020 | Breast Oncology | Ausgabe 2/2021

Axillary Downstaging in Occult Primary Breast Cancer After Neoadjuvant Chemotherapy

Astrid Botty Van den Bruele MD, Jessica Lavery MS, George Plitas MD, Melissa L. Pilewskie MD

13.08.2020 | Breast Oncology | Ausgabe 2/2021

Prognostic Score-Based Stratification Analysis Reveals Universal Benefits of Radiotherapy on Lowering the Risk of Ipsilateral Breast Event for Ductal Carcinoma In Situ Patients with Different Risk Levels

Libo Yang MD, PhD, Dongli Lu PhD, Yutian Lai MD, PhD, Mengjia Shen MD, PhD, Qiuxiao Yu PhD, Ting Lei MD, PhD, Tianjie Pu MD, PhD, Hong Bu MD, PhD

18.08.2020 | Breast Oncology | Ausgabe 2/2021

Smartphone Global Positioning System (GPS) Data Enhances Recovery Assessment After Breast Cancer Surgery

Nikhil Panda MD, MPH, Ian Solsky MD, MPH, Becky Hawrusik MS, Gang Liu MS, Harrison Reeder BA, Stuart Lipsitz ScD, Eesha V Desai BS, Kurt W. Lowery BS, Kate Miller PhD, MPH, Michele A. Gadd MD, Carrie C. Lubitz MD, MPH, Barbara L. Smith MD, PhD, Michelle Specht MD, Jukka-Pekka Onnela DSc, Alex B. Haynes MD, MPH

23.11.2020 | Colorectal Cancer | Ausgabe 2/2021

The Landmark Series: Chemotherapy for Non-Metastatic Colon Cancer

Salvador Alonso MD, Leonard Saltz MD

14.08.2020 | Gynecologic Oncology | Ausgabe 2/2021

Vesicovaginal Fistula Repair by Modified Martius Flap: A Step-by-Step Surgical Technique Video

Tiermes Marina MD, Víctor Lago MD, Pablo Padilla PhD, MD, Luis Matute MD, Santiago Domingo PhD, MD

10.06.2020 | Melanoma | Ausgabe 2/2021

Sentinel Lymph Node Biopsy Is Prognostic in Thickest Melanoma Cases and Should Be Performed for Thick Melanomas

Dale Han MD, Gang Han PhD, Monica T. Duque MPH, Steven Morrison BA, Stanley P. Leong MD, Mohammed Kashani-Sabet MD, John Vetto MD, Richard White MD, Schlomo Schneebaum MD, Barbara Pockaj MD, Nicola Mozzillo MD, Vernon K. Sondak MD, Jonathan S. Zager MD

12.06.2020 | ASO Author Reflections | Ausgabe 2/2021

ASO Author Reflections: Sentinel Lymph Node Biopsy is Prognostic in the Thickest Melanoma Cases and Should be Performed for Thick Melanomas

Steven Morrison BA, Dale Han MD, FACS

11.06.2020 | Melanoma | Ausgabe 2/2021

The Clinical Utility of Neuron-Specific Enolase (NSE) Serum Levels as a Biomarker for Merkel Cell Carcinoma (MCC)

Linde M. van Veenendaal MD, Eduardo Bertolli MD, PhD, Catharina M. Korse PhD, W. Martin C. Klop MD, PhD, Margot E. T. Tesselaar MD, PhD, Alexander C. J. van Akkooi MD, PhD

15.06.2020 | Melanoma | Ausgabe 2/2021 Open Access

Quantitative and Spatial Analysis of CD8+/PD-1 Tumor-Infiltrating Lymphocytes as a Predictive Biomarker for Clinical Response of Melanoma In-Transit Metastases to Topical Immunotherapy

Sophia Haywood MB, BS, Jennifer Garioch MD, FRCP, Arjun Ramaiya FRCPath, Marc Moncrieff MD, FRCS(Plast)

18.09.2020 | Pancreatic Tumors | Ausgabe 2/2021

The Landmark Series: Pancreatic Neuroendocrine Tumors

Jordan M. Cloyd MD, George A. Poultsides MD, MS

24.09.2020 | ASO Author Reflections | Ausgabe 2/2021

ASO Author Reflections: Refining the Surgical Management of Pancreatic Neuroendocrine Tumors

Jordan M. Cloyd MD, George A. Poultsides MD, MS

21.10.2020 | Pancreatic Tumors | Ausgabe 2/2021

The Landmark Series: Mitigation of the Postoperative Pancreatic Fistula

George Van Buren II MD, Charles M. Vollmer Jr. MD

23.09.2020 | Pancreatic Tumors | Ausgabe 2/2021

Elucidating the Causes of Improved Survival in Clinical Trials of Randomized Adjuvant Pancreatic Ductal Adenocarcinoma (PDAC)

Andre Alabd MD, Andrew Alabd MD, Oloruntoba Bolaji DO, Kavin Sugumar MD, John Ammori MD, Jeffrey Hardacre MD, Jordan M. Winter MD

08.06.2020 | Pancreatic Tumors | Ausgabe 2/2021

A Standard Set of Value-Based Patient-Centered Outcomes for Pancreatic Carcinoma: An International Delphi Survey

Zineb Cherkaoui MD, Cristians González MD, Taiga Wakabayashi MD, Bastien Delattre, Elodie Léost, Sébastien Serra MD, Jerôme Huppertz MD, Francine Klein, Marie Stéphan, Jean-Michel Meyer, Alain Schaff, Elisa Martinis, Elena Bangoura, Sophie Kieffer, Sophie Blanès, Elham Haddad, Gabrielle De Guio MD, Emanuele Felli MD, Sophie Pernot, Jacques Marescaux MD, FACS, Hon FRCS, Hon JSES, Hon FASA, Didier Mutter MD, PhD, Constance Lugiez, Patrick Pessaux MD, PhD, IHU-VBHC Working Group

25.06.2020 | Pancreatic Tumors | Ausgabe 2/2021 Open Access

Predictors for Survival in an International Cohort of Patients Undergoing Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma

M. Korrel BSc, S. Lof MD, J. van Hilst MD, MSc, PhD, A. Alseidi MD, U. Boggi MD, PhD, O. R. Busch MD, PhD, S. van Dieren MSc, PhD, B. Edwin MD, PhD, D. Fuks MD, PhD, T. Hackert MD, PhD, T. Keck MD, PhD, I. Khatkov MD, PhD, G. Malleo MD, PhD, I. Poves MD, PhD, M. A. Sahakyan MD, PhD, C. Bassi MD, PhD, M. Abu Hilal MD, PhD, FRCS, FACS, M. G. Besselink MD, MSc, PhD, for the European Consortium on Minimally Invasive Pancreatic Surgery (E-MIPS)

10.07.2020 | Pancreatic Tumors | Ausgabe 2/2021

Racial Disparity in Pancreatoduodenectomy for Borderline Resectable Pancreatic Adenocarcinoma

George Molina MD, MPH, Thomas E. Clancy MD, Thomas C. Tsai MD, MPH, Miranda Lam MD, MBA, Jiping Wang MD, PhD

20.07.2020 | Pancreatic Tumors | Ausgabe 2/2021

Relationship between Cancer Diagnosis and Complications Following Pancreatoduodenectomy for Duodenal Adenoma

Nina L. Eng MD, Danielle E. Mustin BS, Brendan P. Lovasik MD, Michael K. Turgeon MD, Adriana C. Gamboa MD, Mihir M. Shah MD, Kenneth Cardona MD, Juan M. Sarmiento MD, Maria C. Russell MD, Shishir K. Maithel MD, Jeffrey M. Switchenko PhD, David A. Kooby MD

25.06.2020 | Pancreatic Tumors | Ausgabe 2/2021

Distal Pancreatectomy with Celiac Axis Resection (Modified Appleby Procedure) and Arterial Reconstruction for Locally Advanced Pancreatic Adenocarcinoma After FOLFIRINOX Chemotherapy and Chemoradiation Therapy

Pierre-Emmanuel Colombo MD, PhD, François Quenet MD, Pierre Alric MD, PhD, Anne Mourregot MD, Mathias Neron MD, Fabienne Portales MD, Philippe Rouanet MD, PhD, Guillaume Carrier MD

25.08.2020 | Peritoneal Surface Malignancy | Ausgabe 2/2021

Primary Tumor Location and Outcomes After Cytoreductive Surgery and Intraperitoneal Chemotherapy for Peritoneal Metastases of Colorectal Origin

Mohammad Adileh MD, Jonathan B. Yuval MD, Henry S. Walch MS, Walid K. Chatila MS, Rona Yaeger MD, Julio Garcia-Aguilar MD, PhD, Nikolaus Schultz PhD, Philip B. Paty MD, Andrea Cercek MD, Garrett M. Nash MD, MPH

03.08.2020 | Peritoneal Surface Malignancy | Ausgabe 2/2021

Total Parietal Peritonectomy Can Be Performed with Acceptable Morbidity for Patients with Advanced Ovarian Cancer After Neoadjuvant Chemotherapy: Results From a Prospective Multi-centric Study

Aditi Bhatt MS, MCh, Praveen Kammar MS, MCh, Snita Sinukumar MS, MCh, Loma Parikh MD, Nutan Jumle MD, Sakina Shaikh BHMS, MBA, Sanket Mehta DNB

05.08.2020 | Peritoneal Surface Malignancy | Ausgabe 2/2021 Open Access

Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study

T. Susanna Meijer MD, Mark C. Burgmans MD, PhD, Eleonora M. de Leede MD, Lioe-Fee de Geus-Oei MD, PhD, Bas Boekestijn MD, Henricus J. M. Handgraaf MD, PhD, Denise E. Hilling MD, PhD, Jacob Lutjeboer, Jaap Vuijk MD, PhD, Christian H. Martini MD, PhD, Arian R. van Erkel MD, PhD, Rutger W. van der Meer MD, PhD, Fred G. J. Tijl, Frank M. Speetjens MD, PhD, Ellen Kapiteijn MD, PhD, Alexander L. Vahrmeijer MD, PhD

22.06.2020 | Sarcoma | Ausgabe 2/2021

Extraskeletal Myxoid Chondrosarcoma with Molecularly Confirmed Diagnosis: A Multicenter Retrospective Study Within the Italian Sarcoma Group

Anna Paioli MD, Silvia Stacchiotti MD, Domenico Campanacci MD, Emanuela Palmerini MD, PhD, Anna Maria Frezza MD, Alessandra Longhi MD, Stefano Radaelli MD, Davide Maria Donati MD, PhD, Giovanni Beltrami MD, Giuseppe Bianchi MD, Marta Barisella MD, Alberto Righi MD, PhD, Stefania Benini DSc, Marco Fiore MD, Piero Picci MD, Alessandro Gronchi MD

06.07.2020 | Sarcoma | Ausgabe 2/2021

Inoperable Primary Retroperitoneal Sarcomas: Clinical Characteristics and Reasons Against Resection at a Single Referral Institution

Andraz Perhavec MD, Salvatore Provenzano MD, Marco Baia MD, Claudia Sangalli MD, Carlo Morosi MD, Marta Barisella MD, Chiara Colombo MD, Stefano Radaelli MD, Sandro Pasquali MD, Dario Callegaro MD, Alessandro Gronchi MD, Marco Fiore MD

13.07.2020 | Sarcoma | Ausgabe 2/2021

Orthopedic Surgical Treatment and Perioperative Complications in Multiple Myeloma Bone Disease: Analysis of a Series (2009–2018)

María Galán-Olleros MD, Javier Marco MD, PhD, David Oteo MD, Rafael Cristóbal-Bilbao MD, Elena Manrique MD, Roberto García-Maroto MD, Fernando Marco MD, PhD, Juan Luis Cebrián-Parra MD, PhD

05.08.2020 | Translational Research | Ausgabe 2/2021 Open Access

Prognostic Role of Mismatch Repair Status, Histotype and High-Risk Pathologic Features in Stage II Small Bowel Adenocarcinomas

Alessandro Vanoli MD, PhD, Federica Grillo MD, Camilla Guerini MD, Giuseppe Neri MD, Giovanni Arpa MD, Catherine Klersy MD, Gabriella Nesi MD, PhD, Paolo Giuffrida MD, Gianluca Sampietro MD, Sandro Ardizzone MD, Paolo Fociani MD, Roberto Fiocca MD, Giovanni Latella MD, Fausto Sessa MD, Antonietta D’Errico MD, Deborah Malvi MD, Claudia Mescoli MD, PhD, Massimo Rugge MD, Stefano Ferrero MD, Gilberto Poggioli MD, Fernando Rizzello MD, PhD, Maria C. Macciomei MD, Donatella Santini MD, Umberto Volta MD, Roberto De Giorgio MD, PhD, Giacomo Caio MD, PhD, Antonio Calabrò MD, Carolina Ciacci MD, Maria D’Armiento MD, PhD, Aroldo Rizzo MD, Gaspare Solina MD, PhD, Michele Martino BSc, Francesco Tonelli MD, Vincenzo Villanacci MD, Renato Cannizzaro MD, Vincenzo Canzonieri MD, Ada Maria Florena MD, Livia Biancone MD, PhD, Giovanni Monteleone MD, PhD, Roberto Caronna MD, PhD, Antonio Ciardi MD, Luca Elli MD, PhD, Flavio Caprioli MD, PhD, Maurizio Vecchi MD, Renata D’Incà MD, Fabiana Zingone MD, PhD, Anna D’Odorico MD, Marco Vincenzo Lenti MD, Barbara Oreggia MD, Luca Reggiani Bonetti MD, PhD, Antonino Giulio Giannone MD, Augusto Orlandi MD, Valeria Barresi MD, PhD, Rachele Ciccocioppo MD, Giuseppe Amodeo MD, Elena Biletta MD, Ombretta Luinetti MD, PhD, Paolo Pedrazzoli MD, Andrea Pietrabissa MD, Gino Roberto Corazza MD, Enrico Solcia MD, PhD, Marco Paulli MD, PhD, Antonio Di Sabatino MD

07.08.2020 | Translational Research | Ausgabe 2/2021

Prognostic Significance of Circulating Tumor Cells with Mesenchymal Phenotypes in Patients with Gastric Cancer: A Prospective Study

Yui Ishiguro MD, Hideyasu Sakihama MD, PhD, Tadashi Yoshida MD, PhD, Nobuki Ichikawa MD, PhD, Shigenori Homma MD, PhD, Moto Fukai MD, PhD, Hideki Kawamura MD, PhD, Norihiko Takahashi MD, PhD, Akinobu Taketomi MD, PhD

14.05.2020 | Translational Research and Biomarkers | Ausgabe 2/2021

Intraperitoneal CMP-001: A Novel Immunotherapy for Treating Peritoneal Carcinomatosis of Gastrointestinal and Pancreaticobiliary Cancer

Ann M. Miller PhD, Caitlin D. Lemke-Miltner PhD, Sue Blackwell MS, Ann Tomanek-Chalkley BS, Katherine N. Gibson-Corely DVM, PhD, Kristen L. Coleman PhD, George J. Weiner MD, Carlos H. F. Chan MD, PhD

05.06.2020 | Translational Research and Biomarkers | Ausgabe 2/2021 Open Access

Distal Gastrectomy with Billroth II Reconstruction is Associated with Oralization of Gut Microbiome and Intestinal Inflammation: A Proof-of-Concept Study

Angela Horvath PhD, Augustinas Bausys MD, Rasa Sabaliauskaite PhD, Eugenijus Stratilatovas MD, PhD, Sonata Jarmalaite PhD, Burkhard Schuetz PhD, Philipp Stiegler MD, PhD, Rimantas Bausys MD, PhD, Vanessa Stadlbauer MD, PhD, Kestutis Strupas MD, PhD

10.06.2020 | Translational Research and Biomarkers | Ausgabe 2/2021

Clinical Significance of Pretherapeutic Serum Squamous Cell Carcinoma Antigen Level in Patients with Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma

Akihiko Okamura MD, PhD, Satoru Matsuda MD, PhD, Shuhei Mayanagi MD, PhD, Jun Kanamori MD, PhD, Yu Imamura MD, PhD, Tomoyuki Irino MD, PhD, Hirofumi Kawakubo MD, PhD, Shinji Mine MD, PhD, Hiroya Takeuchi MD, PhD, Yuko Kitagawa MD, PhD, Masayuki Watanabe MD, PhD

11.06.2020 | Translational Research and Biomarkers | Ausgabe 2/2021

CD36 Expression Is Associated with Cancer Aggressiveness and Energy Source in Esophageal Squamous Cell Carcinoma

Tomonori Yoshida MD, Takehiko Yokobori MD, PhD, Hideyuki Saito MD, Kengo Kuriyama MD, Yuji Kumakura MD, PhD, Hiroaki Honjo MD, PhD, Keigo Hara MD, PhD, Makoto Sakai MD, PhD, Tatsuya Miyazaki MD, PhD, Hideru Obinata PhD, Bilguun Erkhem-Ochir MD, Navchaa Gombodorj MD, PhD, Makoto Sohda MD, PhD, Hiroshi Saeki MD, PhD, Hiroyuki Kuwano MD, PhD, Ken Shirabe MD, PhD

01.07.2020 | Translational Research and Biomarkers | Ausgabe 2/2021

Correlation Between Immunoinflammatory Measures and Periostin Expression in Esophageal Squamous Cell Carcinoma: A Single-Center, Retrospective Cohort Study

Yusuke Ishibashi MD, Hironori Tsujimoto MD, PhD, Takahiro Einama MD, PhD, Satsuki Mochizuki PhD, Keita Kouzu MD, Shinsuke Nomura MD, Nozomi Ito MD, Manabu Harada MD, Hidekazu Sugasawa MD, PhD, Eiji Shinto MD, PhD, Yoji Kishi MD, PhD, Hideki Ueno MD, PhD

06.07.2020 | Urologic Oncology | Ausgabe 2/2021 Open Access

Nephron-Sparing Surgery for Adult Xp11.2 Translocation Renal Cell Carcinoma at Clinical T1 Stage: A Multicenter Study in China

Ning Liu PhD, Feng Qu PhD, Qiancheng Shi PhD, Wenyuan Zhuang PhD, Wenliang Ma MD, Zhenhao Yang MD, Jing Sun MD, Wei Xu PhD, Lihua Zhang PhD, Ruipeng Jia PhD, Linfeng Xu PhD, Xiaozhi Zhao PhD, Xiaogong Li MD, Gutian Zhang MD, Hongqian Guo PhD, Dongmei Li PhD, MD, Weidong Gan PhD

10.07.2020 | Urologic Oncology | Ausgabe 2/2021

Conditional Survival and Time of Biochemical Recurrence of Localized Prostate Cancer in Japanese Patients Undergoing Laparoscopic Radical Prostatectomies

Masayoshi Kawakami MD, Masanori Hasegawa MD, PhD, Koichiro Yamada MS, Keisuke Shigeta MD, Izumi Hanada MD, Tatsuya Otaki MD, Kentaro Nagao MD, Tatsuya Umemoto MD, Yuuki Shimizu MD, Hakushi Kim MD, PhD, Nobuyuki Nakajima MD, PhD, Masahiro Nitta MD, PhD, Kazuya Hanai MD, Yoshiaki Kawamura MD, PhD, Sunao Shoji MD, PhD, Akira Miyajima MD, PhD

24.07.2020 | Urologic Oncology | Ausgabe 2/2021 Open Access

Three Different Learning Curves Have an Independent Impact on Perioperative Outcomes After Robotic Partial Nephrectomy: A Comparative Analysis

Philip Zeuschner MD, Irmengard Meyer MD, Stefan Siemer MD, Michael Stoeckle MD, Gudrun Wagenpfeil PGD, Stefan Wagenpfeil PGD, Matthias Saar MD, Martin Janssen MD

Aktuelle Ausgaben

Neu im Fachgebiet Chirurgie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Chirurgie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise